The ubiquitin-mediated proteolytic pathway as a therapeutic area

Journal of Molecular Medicine

Volumn 75, Issue 1, 1997, Pages 5-17

  Rolfe, Mark ^a   Chiu, M Isabel ^a   Pagano, Michele ^a,b  

^a GPC Biotech Inc   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

antiproliferative agents; autoimmunity; cancer; cancer therapy; inflammation; ubiquitination

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; PROTEIN P53; REGULATOR PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

AUTOIMMUNITY; CANCER; CELL METABOLISM; CELL PROLIFERATION; ETIOLOGY; HUMAN; INFLAMMATION; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTIFUNGAL AGENTS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; ENDOPEPTIDASES; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

EID: 0031021991     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050081     Document Type: Review

References (139)

1. Alkalay K, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y (1995) Stimulation-dependent IκBa phosphorylation marks the NFκB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 92: 10599-10603
2. Aristarkhov A, Eytan E, Moghe A, Adom A, Hershko A, Ruderman J (1996) E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins. Proc Natl Acad Sci 93:4294-4299
3. Avantaggiati M, Carbone M, Graessman A, Nakatani Y, Howard B, Levine A (1996) The SV40 large T antigen and adenovirus E1A oncoproteins interact with distinct isoforms of the transcriptional co-activator p300. EMBO J 15:2236-2248
4. Baeuerle P, Henkel T (1994) Function and activation of NfKB in the immunosystem. Annu Rev Immunol 12:141-179
5. Baker R, Tobias JW, Varshavsky A (1992) Ubiquitin-specific proteases of Saccharomyces cerevisiae. Cloning of UBP2 and UBP3, and functional analysis of the UBP gene family. J Biol Chem 267:23364-23375
6. Berns A (1994) Is p53 the only real tumor suppressor gene? Curr Biol 4:137-139
7. Britta-Mareen E, Heike T, Pahl H, Henkel T, Schmidt K, Wilk S, Baeuerle P (1995) Phosphorylation of human IκB-a on serine 32 and 36 controls proteolysis and NFκB activation in response to diverse stimuli. EMBO J 14:2876-2883
8. Brown K, Gersterberg S, Carlson S, Franzoso G, Siebenlist U (1995) Control of IκB-a proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1487
9. Cenciarelli C, Hou D, Rellahan B, Smith H, Fried V, Weissman A (1992) Activation-induced ubiquitination of the T cell antigen receptor. Science 257:795-797
10. Chen Z, Hagler J, Palombella V, Melandri F, Scherer D, Ballard D, Maniatis T (1995) Signal-induced site specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 9:1586-1597
11. Chen Z, Parent L, Maniatis T (1996) Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862
12. Chiou S, Rao L, White E (1994) Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14:2556-2563
13. Ciechanover A (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79:13-21
14. Ciechanover A, DiGiuseppe J, Bercovich B, Orian A, Richter J, Schwartz A, Brodeur G (1991) Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci USA 88:139-143
15. Cook W, Jeffrey L, Sullivan M, Vierstra R (1992) Three-dimensional structure of a ubiquitin-conjugating enzyme (E2). J Biol Chem 267:15116-15121
16. Cook W, Jeffrey L, Xu Y, Chau V (1993) Tertiary structures of class I ubiquitin-conjugating enzymes are highly conserved: crystal structure of yeast Ubc4. Biochemistry 32:13809-17
17. Deshaies RJ (1995) Make it or break it: the role of ubiquitin-dependent proteolysis in cell regulation. Trends Cell Biol 10: 428-434
18. Deshaies RJ (1995) The self-destructive personality of a cell cycle in transition. Curr Opin Cell Biol 7:781-789
19. Deshaies RJ, Chau V, Kirschner MW (1995) Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J 14:303-312
20. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel J, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221
21. Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D (1989) cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell 56:829-838
22. Dulic V, Kaufmann W, Wilson S, Tlsty T, Lees E, Harper W, Elledge S, Reed S (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023
23. Dyson N, Howley PM, Münger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 242:934-937
24. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent J M, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
25. Falquet L, Paquet N, Frutiger S, Hughes GJ, Hoang-Van K, Jaton J C (1995) cDNA cloning of a human 100 kDa deubiquitinating enzyme: the 100 kDa human de-ubiquitinase belongs to the ubiquitin C-terminal hydrolase family 2 (UCH2). FEBS Letters 376:233-237
26. Farthing A, Vousden KH (1994) Functions of human papillomavirus E6 and E7 oncoproteins. Trends Microbiol 2:170-175
27. Fenteany G, Standaert R, Lane W, Choi S, Corey E, Schreiber S (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-728
28. Finco T, Beg A, Baldwin A (1994) Inducible phosphorylation of IκBa is not sufficient for for its dissociation from NFκB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 91:11884-11888
29. Firpo EJ, Koff A, Solomon M, Roberts J (1994) Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 14:4889-4901
30. Fischer-Vize JA, Rubin GM, Lehmann R (1992) The fat facets gene is required for Drosophila eye and embryo development. Development 116:985-1000
31. Galcheva-Gargova Z, Theroux S, Davis R (1995) The epidermal growth factor receptor is covalently linked to ubiquitin. Oncogene 11:2649-2655
32. Gallant P, Nigg E (1992) Cyclin B2 undergoes cell cycle dependent nuclear translocation and, when expressed as a non destructable mutant, causes mitotic arrest in HeLa cells. J Cell Biol 117:213-224
33. Giordano A, Whyte P, Harlow E, Franza BR, Beach D, Draetta G (1989) A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell 58:981-990
34. Glotzer M, Murray A, Kirschner M (1991) Cyclin is degraded by the ubiquitin pathway. Nature 349:132-138
35. Gray, DA, Inazawa J, Gupta K, Wong A, Ueda R, Takahashi T (1995) Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors. Oncogene 10:2179-2183
36. Gupta K, Copeland NG, Gilbert DJ, Jenkins NA, Gray DA (1993) Unp, a mouse gene related to the tre oncogene. Oncogene 8:2307-2310
37. Gupta K, Chevrette M, Gray DA (1994) The Unp proto-oncogene encodes a nuclear protein. Oncogene 9:1729-1731
38. Hadari T, Warms JVB, Rose IA, Hershko A (1992) A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. J Biol Chem 267:719-727
39. Han J, Sabbatini P, Perez D, Rao L, Modha D, White E (1996) The E1B 19 K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 10:461-477
40. Harris C, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Eng J Med 329:1318-27
41. Hedge A, Goldberg A, Schwartz J (1993) Regulatory subunits of cAMP-dependent protein kinases degraded after conjugation to ubiquitin: a molecular mechanism underlying lomg-term synaptic plasticity. Proc Natl Acad Sci USA 90:7436-7440
42. Kip1 accumulation during the cell cycle. Science 271:1861-1864
43. Hermida-Matsumoto M, Boon-Chock P, Curran T, Yang D (1996) Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes. J Biol Chem 271:4930-4936
44. Hershko A, Ganoth D, Pehrson J, Palazzo R, Cohen L (1991) Methylated ubiquitin inhibits cyclin degradation in clam embryo extract. J Biol Chem 266:16376-16379
45. Hershko A, Ganoth D, Sudakin V, Dahan A, Cohen L, Luca F, Ruderman J, Eytan E (1994) Components of a system that ligates cyclin to ubiquitin and their regulation by the protein kinase cdc2. J Biol Chem 269:4940-4946
46. Hochstrasser M (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 7:215-223
47. Holloway S, Glotzer M, King R, Murray A (1993) Anaphase is initiated by proteolysis rather than by inactivation of maturation-promoting factor. Cell 73:1393-1402
48. Huang Y, Baker RT, Fischer-Vize JA (1995) Control of cell fate by a deubiquitinating enzyme encoded by the fat facets gene. Science 270:1828-1831
49. Huibregtse J, Scheffner M, Howley P (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10:4129-4135
50. Huibregtse J, Scheffner M, Beaudenon S, Howley P (1995) A family of proteins structurally and functionally related to E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 92: 2563-2567
51. Irniger S, Piatti S, Michaelis C, Nasmyth K (1995) Genes involved in sister chromatid separation are needed for B-type cyclin proteolysis in budding yeast. Cell 81:269-277
52. Jennissen HP (1995) Ubiquitin and the enigma of intracellular protein degradation. Eur J Biochem 231:1-30
53. Jensen J, Bates P, Yang M, Vierstra R, Weissman A (1995) Identification of a family of closely related human ubiquitin conjugating enzymes. J Biol Chem 270:30408-30414
54. Jensen T, Loo M, Pind S, Williams D, Goldberg A, Riordan J (1995) Multiple proteolytic systems including the proteasome, contribute to CTRF processing. Cell 83:129-135
55. Jentsch S, Schlenker S (1995) Selective protein degradation: a journey's end within the proteasome. Cell 82:881-884
56. Kaiser P, Seufert W, Hoefferer L, Kofler B, Sachsenmair C, Herzog H, Jentsch S, Schweiger M, Schneider R (1994) A human ubiquitin-conjugating enzyme homologous to yeast UBC8. J Biol Chem 269:8797-8802
57. Kanda F, Sykes DE, Yasuda H, Sandberg AA, Matsui S (1986) Substrate recognition of isopeptidase: specific cleavage of the epsilon-(alpha-glycyl) lysine linkage in ubiquitin-protein conjugates. Biochim Biophys Acta 870:64-75
58. Kawamat AN, Morosetti R, Miller C, Park D, Spirin K, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee Y, Bartram C, Koeffler H (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/kip1 in human malignancies. Cancer Res 55:2266-2269
59. King R, Peters J, Tugendreich S, Rolfe M, Hieter P, Kirschner M (1995) A 20S complex containing Cdc27 and Cdc16 catakyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81:279-288
60. Koken M, Reynolds P, Jaspers-Dekker I, Prakash L, Prakash S, Bootsma D, Hoeijmakers J (1991) Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6. Proc Natl Acad Sci USA 88:8865-8869
61. Kovalenko O, Plug A, Haaf T, Gonda D, Ashley T, Ward D, Radding C, Golub E (1996) Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizzes in synaptonemal complexes. Proc Natl Acad Sci USA 93:2958-2963
62. Lane DP, Crawford LV (1979) T-antigen is bound to host protein in SV40-transformed cells. Nature 278:261-263
63. Lane DP, Lu X, Hupp T, Hall PA (1994) The role of the p53 protein in the apoptotic response. Philos Trans R Soc Lond B Biol Sci 345:277-80
64. Lees E (1995) Cyclin dependent kinase regulation. Curr Opin Cell Biol 773-780
65. Lin W, Desiderio S (1993) Regulation of V(D)J recombination activator protein RAG-2 by phosphorylation. Science 260:953-959
66. Lin L, Ghosh S (1996) A glycine-reach region in NF-κB p 105 functions as a processing signal for the generetion of the p50 subunit. Mol Cell Biol 16:2248-2254
67. Lin Y, Bown K, Siebenlist U (1995) Activation of NFκB requires proteolysis of the inhibitor IκB-a: signal-incduced phosphorylation of IκB-a alone does not release active NFκB. Proc Natl Acad Sci USA 92:552-556
68. Linzer D, Levine A (1979) Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43-52
69. Liu Z, Diaz L, Haas A, Giudice G (1992) cDNA cloning of a novel human ubiquitin carrier protein. J Biol Chem 267: 15829-15835
70. Loda M, Cukon B, Tam S, Lavin P, Fiorentino M, Draetta G, Jessup J, Pagano M (1996) p27 is an independent prognostic marker in colorectal carcinoma. (submitted)
71. 2+-calmodulin dependent event. EMBO J 10:2087-2093
72. Luca FC, Ruderman JV (1989) Control of programmed cyclin destruction in a cell-free system. J Cell Biol 109:1895-1909
73. Luca F, Shibuya H, Dohrmann C, Ruderman J (1991) Both cyclin AΔ60 and BΔ97 are stable and arrest cells in M-phase, but only cyclin BΔ97 turns on cyclin destruction. EMBO J 10:4311-4320
74. MacLachlan T, Sang N, Giordano A (1995) Cyclins, cyclin-dependent kinases and Cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryotic Gene Expression 5:127-156
75. Magae J, Illenye S, Wells J, Heintz NH (1996) Deregulated expression of E2F-1 and DP-1 reveals distinct effects on G1-specific gene expression and cell cycle progression. (submitted)
76. Maki C, Hulbregtse J, Howley P (1996) In vivo ubiquitination targets wild-type p53 for degradation by the proteasome. (submitted)
77. Mal A, Poon R, Howe P, Toyoshima H, Hunter T, Harter M (1996) Inactivation of p27kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380:262-265
78. Matlashewski G, Banks L, Pim D, Crawford L (1986) Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur J Biochem 154:665-672
79. Miyashita T, Reed J (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
80. Miyashita T, Krajewski S, Krajewska M, Wang H, Lin H, Liebermann D, Hoffman B, Reed J (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805
81. Moran E (1993) DNA tumor virus transforming proteins and the cell cycle. Curr Opin Gen Dev 3:63-70
82. Mori S, Tanaka K, Omura S, Saito Y (1995) Degradation process of ligand-stimulated platelet-derived growth factor β-receptor involves ubiquitin-proteasome proteolytic pathway. J Biol Chem 270:29447-29452
83. Murray AW, Solomon MJ, Kirschner MW (1989) The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature 339:280-286
84. Nakamura T, Hillova J, Mariage-Samson R, Onno M, Huebner K, Cannizzaro LA, Boghosian-Sell L, Croce CM, Hill M (1992) A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. Oncogene 7:733-741
85. Nirmala P, Thampan R (1995) Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem Biophys Res Commun 213:24-31
86. Nishizawa M, Okazaki K, Furuno N, Watanabe N, Sagata N (1992) The 2nd codon rule and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocyte. EMBO J 11:2433-2447
87. Nourse J, Firpo E, Flanagan M, Coats S, Polyak C, Lee M, Massague J, Crabtree G, Roberts J (1994) Interleukin-2-mediated elimination of p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573
88. Nuber U, Schwarz S, Kaiser P, Schneider R, Scheffner M (1996) Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterisation of their interaction with E6-AP and RSP5. J Biol Chem 271:2795-2800
89. Orian A, Whitedside S, Isral A, Stancovski I, Schwartz A, Ciechanover A (1995) Ubiquitin-mediated processingof NF-kB transcreptional activator precursor p 105. J Biol Chem 270:21707-21714
90. Pagano M, Tam SW, Theodoras AM, Romero-Beer P, Del Sal G, Chau V, Yew R, Draetta G, Rolfe M (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685
91. Palombella V, Rando O, Goldberg A, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785
92. Paolini R, Kinet J (1993) Cell surface control of the multiubiquitination and deubiquitination of high-affinity immunoglobulin E receptors. EMBO J 12:779-786
93. Papa F, Hochstrasser M (1993) The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 366:313-319
94. Papavassiliou A, Treier M, Chavrier C, Bohmann D (1992) Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation signal on c-Jun. Science 258:1941-1944
95. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 55:1206-1210
96. Pines J, Hunter T (1989) Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833-846
97. Plon S, Leppig K, Do H, Groudine M (1993) Cloning of the human homolog of the CDC34 cell cycle gene by complementation in yeast. Proc Natl Acad Sci USA 90:10484-10488
98. kip1. a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 79:59-66
99. Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 55:1211-1214
100. Prives C (1993) Doing the right thing: feedback control and p53. Curr Opin Cell Biol 5:214-218
101. Robinson P, Leek J, Thompson J, Carr I, Bailey A, Moynihan T, Coletta P, Lench N, Markham A (1995) A human ubiiquitin conjugating enzyme, L-UBC, maps in the Alzheimer's disease locus on chromosome 14q24.3. Mammal Genome 6:725-731
102. Rock K, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg A (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771
103. Rogers S, Wells R, Rechsteiner M (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234:364-368
104. Rolfe M, Romero P, Glass S, Eckstein J, Berdo I, Theodoras A, Pagano M, Draetta G (1995) Reconstitution of p53-ubiquitinylation reaction from purified components: the role of human UBC4 and E6AP. Proc Natl Acad Sci USA 92: 3264-3268
105. Rubin D, Finley D (1995) The proteasome: a protein-degrading organelle? Curr Biol 5:854-858
106. Sabbatini P, Chiou S, Rao L, White E (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19 K protein. Mol Cell Biol 15:1060-1070
107. Sarnow P, Ho Y, Williams J, Levine A (1982) Adenovirus E1b 58KD antigen and SV-40 large tumor antigen are physically associated to the same 54 KD cellular protein in transformed cells. Cell 28:387-394
108. Scheffner M, Werness B, Huibregtse J, Levine A, Howley P (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136
109. Scheffner M, Huibregtse J, Vierstra R, Howley P (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505
110. Scheffner M, Huibregtse J, Howley P (1994) Identification of a human ubiquitin-conjugating enzyme that mediates the E6- AP-dependent ubiquitination of p53. Proc Natl Acad Sci USA 91:8797-8801
111. Scheffner M, Nuber U, Huibregtse J (1995) Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373:81-83
112. Scherer D, Brockman J, Chen Z, Maniatis T, Ballard D (1995) Signal-induced degradation of IκBa requires site-specific ubiquitination. Proc Natl Acad Sci USA 92:11259-11263
113. Seufert W, Futcher B, Jentsch S (1995) Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373:78-81
114. Sheaff RJ, Roberts JM (1995) Lesson in p16 from phylum Falconium. Curr Biol 5:28-31
115. Sherr C, Roberts J (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
116. 6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochemistry 35:1328-1334
117. Stancovski I, Gonen H, Orian A, Schwartz A, Ciechanover A (1995) Degradation of the proto-oncogene c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol Cell Biol 15:7106-7116
118. Stegmaier K, Takeuchi S, Golub T, Bhohlander S, Bartram C, Koeffler P, Gilliland G (1996) Mutational analysis of the candidate tumor suppressor genes Tel and Kip1 in childhood acute lymphoblastic leukemia. Cancer Res 56:1413-1417
119. Stein R, Chen Z, Melandri F (1995) Kinetic studies of isopeptidase T: modulation of peptidase activity by ubiquitin. Biochemistry 34:12616-12623
120. Stewart E, Kobayashi H, Harrison D, Hunt T (1994) Destruction of Xenopus cyclins A and B2, but not B1, requires binding to p34Cdc2. EMBO J 13:584-594
121. Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca F, Ruderman J, Hershko A (1995) The cyclosome, a large complex containing cyclin selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 6:185-198
122. Swanson D, Freund C, Ploder L, McInnes R, Valle D (1996) A ubiquitin C-terminal hydrolase gene on the proximal short arm of the chromosome: inplication for X-linked retinal disorder. Human Mol Gen 5:533-538
123. Thanos D, Maniatis T (1995) NF-κB: a lesson in family values. Cell 80:529-532
124. Tobias J, Varshavsky A (1991) Cloning and functional analysis of the ubiquitin-specific protease gene UBP1 or Saccharomyces cerevisiae. J Biol Chem 266:12021-12028
125. Toyoshima, Hunter T (1994) p27, a novel inhibitor of G1-cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74
126. Treier M, Staszewski L, Bohmann D (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the ∂ domain. Cell 78:787-798
127. Tsurumi C, Ishida N, Tamura T, Kakizuka A, Nishida E, Okumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N, Ichihara A, Tanaka K (1995) Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol Cell Biol 15:5682-5687
128. Tugendreich S, Tomkiel J, Earnshaw W, Hieter P (1995) Cdc27Hs colocalizes with Cdc16Hs to the centrosome and milotic spindle and is essential for the metaphase to anaphase transition. Cell 81:261-268
129. cdc2. Mol Biol Cell 5:713-724
130. Ward C, Omura S, Kopito R (1995) Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121-127
131. Watanabe T, Fujiwara T, Kawai A, Shimizu F, Takami S, Hirano H, Okuno S, Ozaki K, Takeda S, Shimada Y, Nagata M, Takaichi A, Takahashi E, Nakamura Y, Shin S (1996) Cloning, expression, and mapping of UBE21, a novel gene encoding a human homologue of yeast ubiquitin-conjugating enzymes which are critical for regulating the cell cycle. Cytogen Cell Gen 72:86-89
132. Werness B, Levine A, Howley P (1990) Association of human papilloma virus types 16 and 18 E6 protein with p53. Science 248:76-79
133. White E (1994) p53, guardan of Rb. Nature 371:21-22
134. Wilkinson, KD, Lee K, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J (1989) The neuron-specific protein PGP9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246:670-673
135. Wilkinson, KD, Tashayev VL, O'Connor LB, Larsen CN, Kasperek E, Pickart CM (1995) Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. Biochemistry 34:14535-14546
136. Xiong Y, Zhang H, Beach D (1993) Subunit rearrangement of the cyclin dependent kinases is associated with cellular transformation. Genes Dev 7:1572-1583
137. Cdc28-mediated control of Cln3 cyclin degradation. Mol Cell Biol 15:731-741
138. Yu H, King R, Peters J, Kirschner M (1996) Identification of a novel ubiquitin-conjugating enzyme involved in milotic cyclin degradation. Curr Biol 6:455-466
139. Zhu Y, Carroll M, Papa F, Hochstrasser M, D'Andrea A (1996) Dub-1, a deubiquitinating enzyme with growth suppressing activity. Proc Natl Acad Sci USA 93:3275-3279